Phase I Study of TSN084 in Patients With Advanced Malignant Tumors.

Clinical trial NCT05300438 · UNKNOWN

Trial details

NCT number: NCT05300438
Sponsor: Tyligand Bioscience (Shanghai) Limited
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

Cancer (With or Without Metastasis)

Start date: 2022-02-18
Primary completion: 2025-03-01
Enrollment: 74

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.